The efficacy of GIP(3-30)NH2 as a GIP receptor antagonist in humans: [Meeting Abstract}

L. S. Gasbjerg, E. J. Bari, S. Stensen, B. Hoe, A. R. Lanng, D. S. Mathiesen, M. B. Christensen, B. Hartmann, J. J. Holst, M. M. Rosenkilde, F. K. Knop

32 Citations (Scopus)
Original languageEnglish
Article number557
JournalDiabetologia
Volume62
Issue numberSupæ. 1/SI
Pages (from-to)S269-S269
ISSN0012-186X
Publication statusPublished - 2019
Event55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) - Barcelona, Spain
Duration: 16 Sept 201920 Sept 2019

Conference

Conference55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)
Country/TerritorySpain
CityBarcelona
Period16/09/201920/09/2019

Cite this